- Home
- UAA vs CPRX Comparison
UAA vs CPRX Comparison
Compare UAA & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAA
- CPRX
- Stock Information
- Founded
- UAA 1996
- CPRX 2002
- Country
- UAA United States
- CPRX United States
- Employees
- UAA N/A
- CPRX N/A
- Industry
- UAA Apparel
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- UAA Consumer Discretionary
- CPRX Health Care
- Exchange
- UAA Nasdaq
- CPRX Nasdaq
- Market Cap
- UAA 2.2B
- CPRX 2.6B
- IPO Year
- UAA N/A
- CPRX 2006
- Fundamental
- Price
- UAA $4.81
- CPRX $21.01
- Analyst Decision
- UAA Hold
- CPRX Strong Buy
- Analyst Count
- UAA 20
- CPRX 5
- Target Price
- UAA $6.88
- CPRX $33.20
- AVG Volume (30 Days)
- UAA 8.6M
- CPRX 1.4M
- Earning Date
- UAA 11-06-2025
- CPRX 11-05-2025
- Dividend Yield
- UAA N/A
- CPRX N/A
- EPS Growth
- UAA N/A
- CPRX 183.96
- EPS
- UAA 0.23
- CPRX 1.65
- Revenue
- UAA $5,114,713,000.00
- CPRX $558,499,000.00
- Revenue This Year
- UAA N/A
- CPRX $16.59
- Revenue Next Year
- UAA $2.72
- CPRX $8.80
- P/E Ratio
- UAA $21.21
- CPRX $12.72
- Revenue Growth
- UAA N/A
- CPRX 28.55
- 52 Week Low
- UAA $4.72
- CPRX $19.05
- 52 Week High
- UAA $11.89
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- UAA 44.86
- CPRX 55.01
- Support Level
- UAA $4.72
- CPRX $20.66
- Resistance Level
- UAA $4.89
- CPRX $21.55
- Average True Range (ATR)
- UAA 0.14
- CPRX 0.61
- MACD
- UAA 0.01
- CPRX 0.04
- Stochastic Oscillator
- UAA 30.88
- CPRX 67.88
About UAA Under Armour Inc.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).